Lincoln Pharmaceuticals Ltd achieves the milestone of Rs. 533 crore Revenue and Rs. 100 crore Profit before Tax for the first time in a Financial Year for FY2022-23
Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd FY23 Results Highlights:– (Standalone) · Net Profit Reports Y-o-Y growth of 5.11% to Rs. 72.90 crore; · Total Income reports Y-o-Y growth of 10.52% to Rs. 532.79 crore; · EBITDA reports Y-o-Y growth of 5.86% to Rs. 111.65 crore. · Company recommends 15% dividend, Rs. 1.5 per share for FY 23 Q4FY23 Results Highlights:– (Standalone) · Net Profit Reports Y-o-Y growth of 14.00% to Rs. 12.56 crore; · Total Income reports Y-o-Y growth of 11.47% to Rs. 116.41 crore; · EBITDA reports Y-o-Y growth of 6.26% to Rs. 20.54 crore. Ahmedabad (Gujarat) [India], May 30: Lincoln Pharmaceuticals Limited, one of India’s leading…